| Psoriasis |
1 |
1 |
| Psoriatic Arthritis |
0 |
0.78 |
| Biomarker |
0 |
0.58 |
| Metabolism |
0 |
0.47 |
| Blood |
0 |
0.35 |
| Cardiovascular Risk Management |
0 |
0.31 |
| Lipids Management |
0 |
0.25 |
| Arthritis |
0 |
0.23 |
| Clinical Research |
0 |
0.23 |
| Scan |
0 |
0.23 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.2 |
| Body Mass Index |
0 |
0.12 |
| Cardiovascular disease |
0 |
0.12 |
| Epidemiology |
0 |
0.12 |
| Food and Drug Administration (FDA) |
0 |
0.12 |
| Heart |
0 |
0.12 |
| Interleukin |
0 |
0.12 |
| Pennsylvania |
0 |
0.12 |
| Phototherapy |
0 |
0.12 |
| Severity Index |
0 |
0.12 |
| Tissue |
0 |
0.12 |
| Tumor |
0 |
0.12 |
| Biologic Therapy |
0 |
0.05 |
| Obesity |
0 |
0.05 |
| Type 2 Diabetes Mellitus |
0 |
0.05 |